Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 37, Issue 6, 2017, Pages 816-822

  Chi, Jie shan ^a,b   Li, Jian zhou ^a   Jia, Jing jing ^a   Zhang, Ting ^a   Liu, Xiao ma ^a   Yi, Li ^a  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

ANRIL; atherosclerosis; duality; gene regulation

Indexed keywords

EID: 85039558050     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-017-1812-y     Document Type: Article

References (77)

1. Pasmant E, Laurendeau I, Heron D, et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res, 2007,67(8):3963–3969
2. Aguilo F, Zhou MM, Walsh MJ. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res, 2011,71(16):5365–5369
3. Dixon RJ, Eperon IC, Hall L, et al. A genome-wide survey demonstrates widespread non-linear mRNA in expressed sequences from multiple species. Nucleic Acids Res, 2005,33(18):5904–5913
4. Schunkert H, Gotz A, Braund P, et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation. 2008,117(13):1675–1684
5. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009,458(7235):223–227
6. Holdt LM, Teupser D. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arteriosclerosis, thrombosis, and vascular biology. 2012,32(2):196–206
7. Biros E, Cooper M, Palmer LJ, et al. Association of an allele on chromosome 9 and abdominal aortic aneurysm. Atherosclerosis. 2010,212(2):539–542
8. Bown MJ, Braund PS, Thompson J, et al. Association between the coronary artery disease risk locus on chromosome 9p21.3 and abdominal aortic aneurysm. Circ Cardiovasc Genet, 2008,1(1):39–42
9. Helgadottir A, Thorleifsson G, Magnusson KP, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008,40(2):217–224
10. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007,316(5830):1491–1493
11. Ye S, Willeit J, Kronenberg F, et al. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol, 2008,52(5):378–384
12. Cluett C, McDermott MM, Guralnik J, et al. The 9p21 myocardial infarction risk allele increases risk of peripheral artery disease in older people. Circ Cardiovasc Genet, 2009,2(4):347–353
13. Gschwendtner A, Bevan S, Cole JW, et al. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol, 2009,65(5):531–539
14. Matarin M, Brown WM, Singleton A, et al. Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. Stroke, 2008,39(5):1586–1589
15. Vaccarino V, Bremner JD, Kelley ME. JUPITER: a few words of caution. Circ Cardiovasc Qual Outcomes. 2009;2(3):286–288.
16. Kotake Y, Nakagawa T, Kitagawa K, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene, 2011,30(16):1956–1962
17. Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Front Genet, 2012,3:219
18. Iacobucci I, Sazzini M, Garagnani P, et al. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leuk Res, 2011,35(8):1052–1059
19. Chen C, Bartenhagen C, Gombert M, et al. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia. Genes Chromosomes Cancer, 2013,52(6):564–579
20. Turnbull C, Ahmed S, Morrison J, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet, 2010,42(6):504–507
21. Bei JX, Li Y, Jia WH, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet, 2010,42(7):599–603
22. Zou ZW, Ma C, Medoro L, et al. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget, 2016,7(38):61741–61754
23. Cunnington MS, Santibanez Koref M, Mayosi BM, et al. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet, 2010,6(4):e1000899
24. Bishop DT, Demenais F, Iles MM, et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet, 2009,41(8):920–925
25. Boon RA, Jae N, Holdt L, et al. Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets? J Am Coll Cardiol, 2016,67(10):1214–1226
26. Chen H, Xin Y, Zhou L, et al. Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma. Med Oncol, 2014,31(11):246
27. Chidlow G, Wood JP, Sharma S, et al. Ocular expression and distribution of products of the POAG-associated chromosome 9p21 gene region. PLoS One, 2013,8(9):e75067
28. Nie FQ, Sun M, Yang JS, et al. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther, 2015,14(1):268–277
29. Wibom C, Spath F, Dahlin AM, et al. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev, 2015,24(5):810–816
30. Lu Y, Zhou X, Xu L, et al. Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer. Onco Targets Ther, 2016,9:3077–3084
31. Naemura M, Tsunoda T, Inoue Y, et al. ANRIL regulates the proliferation of human colorectal cancer cells in both two-and three-dimensional culture. Mol Cell Biochem, 2016,412(1-2):141–146
32. Peng L, Yuan X, Jiang B, et al. LncRNAs: key players and novel insights into cervical cancer. Tumour Biol, 2016,37(3):2779–2788
33. Pasmant E, Sabbagh A, Masliah-Planchon J, et al. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J Natl Cancer Inst, 2011,103(22):1713–1722
34. Zhu H, Li X, Song Y, et al. Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway. Biochem Biophys Res Commun, 2015,467(2):223–228
35. Yuan W, Wu T, Fu H, et al. Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation. Science, 2012,337(6097):971–975
36. Bernard D, Martinez-Leal JF, Rizzo S, et al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene, 2005,24(36):5543–5551
37. Yap KL, Li S, Munoz-Cabello AM, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell, 2010,38(5):662–674
38. Schmid CW, Deininger PL. Sequence organization of the human genome. Cell, 1975,6(3):345–358
39. Kriegs JO, Churakov G, Jurka J, et al. Evolutionary history of 7SL RNA-derived SINEs in Supraprimates. Trends Genet, 2007,23(4):158–161
40. Holdt LM, Hoffmann S, Sass K, et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet, 2013,9(7):e1003588
41. Jarinova O, Stewart AF, Roberts R, et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol, 2009,29(10):1671–1677
42. Yoshida. ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Oncol Rep, 2010,24(3):701–707
43. Robertson KD, Jones PA. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol, 1998,18(11):6457–6473
44. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Can Cell, 2002,2(2):103–112
45. Wan G, Mathur R, Hu X, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal, 2013,25(5):1086–1095
46. Rodriguez C, Borgel J, Court F, et al. CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus. Biochem Biophys Res Commun, 2010;392(2):129–134
47. Lagrue G, Niaudet P, Guillot F, et al. Pregnancy and glomerulonephritis. Lancet, 1989,2(8670):1037
48. Huang MD, Chen WM, Qi FZ, et al. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2. J Hematol Oncol, 2015,8(1):57
49. Congrains A, Kamide K, Katsuya T, et al. CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun, 2012,419(4):612–616
50. Schaefer AS, Bochenek G, Jochens A, et al. Genetic evidence for PLASMINOGEN as a shared genetic risk factor of coronary artery disease and periodontitis. Circ Cardiovasc Genet, 2015,8(1):159–167
51. Burdon KP, Macgregor S, Hewitt AW, et al. Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet, 2011,43(6):574–578
52. Burdon KP, Crawford A, Casson RJ, et al. Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma. Ophthalmology, 2012,119(8):1539–1545
53. Schaefer AS, Bochenek G, Manke T, et al. Validation of reported genetic risk factors for periodontitis in a large-scale replication study. J Clini Periodontol, 2013,40(6):563–572
54. Masharawi YM, Kjaer P, Bendix T, et al. Lumbar facet and interfacet shape variation during growth in children from the general population: a three-year follow-up MRI study. Spine, 2009,34(4):408–412
55. Foroud T, Koller DL, Lai D, et al. Genome-wide association study of intracranial aneurysms confirms role of Anril and SOX17 in disease risk. Stroke, 2012,43(11):2846–2852
56. Kremer PH, Koeleman BP, Pawlikowska L, et al. Evaluation of genetic risk loci for intracranial aneurysms in sporadic arteriovenous malformations of the brain. J Neurol Neurosurg Psychiatry, 2015,86(5):524–529
57. Bai Y, Nie S, Jiang G, et al. Regulation of CARD8 Expression by ANRIL and Association of CARD8 Single Nucleotide Polymorphism rs2043211 (p.C10X) With Ischemic Stroke. Stroke, 2014,45(2):383–388
58. Congrains A, Kamide K, Oguro R, et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis, 2012,220(2):449–455
59. Lan WG, Xu DH, Xu C, et al. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells. Oncol Rep, 2016,36(1):263–270
60. Burd CE, Jeck WR, Liu Y, et al. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet, 2010,6(12):e1001233
61. Liu Y, Sanoff HK, Cho H, et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One, 2009,4(4):e5027
62. Holdt LM, Beutner F, Scholz M, et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol, 2010,30(3):620–627
63. Johnson AD, Hwang SJ, Voorman A, et al. Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study. Circulation, 2013,127(7):799–810
64. Motterle A, Pu X, Wood H, et al. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Hum Mol Genet. 2012,21(18):4021–4029
65. Zhao W, Smith JA, Mao G, et al. The cis and trans effects of the risk variants of coronary artery disease in the Chr9p21 region. BMC Med Genomics, 2015,8:21
66. Holdt LM, Stahringer A, Sass K, et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun, 2016,7:12429
67. Zhou X, Han X, Wittfeldt A, et al. Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-kappaB pathway. RNA Biol, 2016,13(1):98–108
68. Joo M, Wright JG, Hu NN, et al. Yin Yang 1 enhances cyclooxygenase-2 gene expression in macrophages. Am J Physiol Lung Cell Mol Physiol, 2007,292(5):L1219–1226
69. Guo J, Casolaro V, Seto E, et al. Yin-Yang 1 activates interleukin-4 gene expression in T cells. J Biol Chem, 2001,276(52):48871–48878
70. Hasegawa A, Yasukawa M, Sakai I, et al. Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells. J Immunol, 2001,166(2):1125–1131
71. Harismendy O, Notani D, Song X, et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature, 2011,470(7333):264–268
72. Battle TE, Lynch RA, Frank DA. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res, 2006,66(7):3649–3657
73. Katze MG, He Y, Gale M, Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol, 2002,2(9):675–687
74. Xu Z, Wei W, Gagneur J, et al. Antisense expression increases gene expression variability and locus interdependency. Mol Syst Biol, 2011,7:468
75. Camblong J, Beyrouthy N, Guffanti E, et al. Transacting antisense RNAs mediate transcriptional gene cosuppression in S. cerevisiae. Genes Dev, 2009,23(13):1534–1545
76. Gagneur J, Sinha H, Perocchi F, et al. Genome-wide allele-and strand-specific expression profiling. Mol Syst Biol, 2009,5:274
77. Pelechano V, Steinmetz LM. Gene regulation by antisense transcription. Nat Rev Genet, 2013,14(12):880–893